Literature DB >> 18952485

Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.

Owen A Ross1, Cleanthe Spanaki, Alida Griffith, Chin-Hsien Lin, Jennifer Kachergus, Kristoffer Haugarvoll, Helen Latsoudis, Andreas Plaitakis, Joaquim J Ferreira, Cristina Sampaio, Vincenzo Bonifati, Ruey-Meei Wu, Cyrus P Zabetian, Matthew J Farrer.   

Abstract

The Roc domain of the Lrrk2 protein harbors two pathogenic mutations which cause autosomal dominant parkinsonism (R1441C and R1441G). A third putatively pathogenic variant (R1441H) has been identified in four probands of diverse ethnicity with parkinsonism. Herein we show that the R1441H substitutions lie on different haplotypes within our patients, confirming this codon as a mutational hotspot. The absence of this variant in control subjects and the presence of two other pathogenic variants at this amino acid position collectively support the contention that R1441H is a pathogenic substitution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952485      PMCID: PMC2749264          DOI: 10.1016/j.parkreldis.2008.09.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

2.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.

Authors:  C P Zabetian; A Samii; A D Mosley; J W Roberts; B C Leis; D Yearout; W H Raskind; A Griffith
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

3.  LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.

Authors:  Cleanthe Spanaki; Helen Latsoudis; Andreas Plaitakis
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

4.  Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.

Authors:  María C González-Fernández; Elena Lezcano; Owen A Ross; Juan C Gómez-Esteban; Fernando Gómez-Busto; Fernando Velasco; Maite Alvarez-Alvarez; María B Rodríguez-Martínez; Roberto Ciordia; Juan J Zarranz; Matthew J Farrer; Ignacio F Mata; Marian M de Pancorbo
Journal:  Parkinsonism Relat Disord       Date:  2007-05-30       Impact factor: 4.891

5.  Lrrk2 pathogenic substitutions in Parkinson's disease.

Authors:  Ignacio F Mata; Jennifer M Kachergus; Julie P Taylor; Sarah Lincoln; Jan Aasly; Timothy Lynch; Mary M Hulihan; Stephanie A Cobb; Ruey-Meei Wu; Chin-Song Lu; Carlos Lahoz; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

Review 6.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

7.  Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.

Authors:  K Haugarvoll; R Rademakers; J M Kachergus; K Nuytemans; O A Ross; J M Gibson; E-K Tan; C Gaig; E Tolosa; S Goldwurm; M Guidi; G Riboldazzi; L Brown; U Walter; R Benecke; D Berg; T Gasser; J Theuns; P Pals; P Cras; P Paul De Deyn; S Engelborghs; B Pickut; R J Uitti; T Foroud; W C Nichols; J Hagenah; C Klein; A Samii; C P Zabetian; V Bonifati; C Van Broeckhoven; M J Farrer; Z K Wszolek
Journal:  Neurology       Date:  2008-03-12       Impact factor: 9.910

8.  High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.

Authors:  Joaquim J Ferreira; Leonor Correia Guedes; Mário Miguel Rosa; Miguel Coelho; Marina van Doeselaar; Dorothea Schweiger; Alessio Di Fonzo; Ben A Oostra; Cristina Sampaio; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

9.  Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.

Authors:  Owen A Ross; Yih-Ru Wu; Mei-Ching Lee; Manabu Funayama; Meng-Ling Chen; Alexandra I Soto; Ignacio F Mata; Guey-Jen Lee-Chen; Chiung Mei Chen; Michelle Tang; Yi Zhao; Nobutaka Hattori; Matthew J Farrer; Eng-King Tan; Ruey-Meei Wu
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 10.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01
  10 in total
  12 in total

Review 1.  Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications.

Authors:  Iakov N Rudenko; Mark R Cookson
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 2.  Leucine-rich repeat kinase 2 for beginners: six key questions.

Authors:  Lauren R Kett; William T Dauer
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

3.  Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.

Authors:  Anat Bar-Shira; Carolyn M Hutter; Nir Giladi; Cyrus P Zabetian; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2009-03-13       Impact factor: 2.660

Review 4.  LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease.

Authors:  Yulan Xiong; Valina L Dawson; Ted M Dawson
Journal:  Biochem Soc Trans       Date:  2012-10       Impact factor: 5.407

5.  The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot.

Authors:  Ignacio F Mata; Marie Y Davis; Alexis N Lopez; Michael O Dorschner; Erica Martinez; Dora Yearout; Brenna A Cholerton; Shu-Ching Hu; Karen L Edwards; Thomas D Bird; Cyrus P Zabetian
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-04-25       Impact factor: 3.568

6.  Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Authors:  Taku Hatano; Manabu Funayama; Shin-Ichiro Kubo; Ignacio F Mata; Yutaka Oji; Akio Mori; Cyrus P Zabetian; Sarah M Waldherr; Hiroyo Yoshino; Genko Oyama; Yasushi Shimo; Ken-Ichi Fujimoto; Hirokazu Oshima; Yasuto Kunii; Hirooki Yabe; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Neurobiol Aging       Date:  2014-06-02       Impact factor: 4.673

7.  Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Authors:  Ignacio F Mata; Carolyn M Hutter; María C González-Fernández; Marian M de Pancorbo; Elena Lezcano; Cecilia Huerta; Marta Blazquez; Renee Ribacoba; Luis M Guisasola; Carlos Salvador; Juan C Gómez-Esteban; Juan J Zarranz; Jon Infante; Joseph Jankovic; Hao Deng; Karen L Edwards; Victoria Alvarez; Cyrus P Zabetian
Journal:  Neurogenetics       Date:  2009-03-24       Impact factor: 2.660

8.  Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.

Authors:  José M Bravo-San Pedro; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes Rodríguez
Journal:  Parkinsons Dis       Date:  2012-08-30

Review 9.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

Review 10.  LRRK2: cause, risk, and mechanism.

Authors:  Coro Paisán-Ruiz; Patrick A Lewis; Andrew B Singleton
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.